(Q35380239)

English

HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

based on heuristic

inferred from title

author name string

Jaspreet Singh

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Mushfiquddin Khan

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Inderjit Singh

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of Lipid Research

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2056-2069

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Regulation of cellular metabolism by protein lysine acetylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Effect of testosterone metabolites on ABC half-transporter relative gene expression in X-linked adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Therapy of X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Elongation of long-chain fatty acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Treatment of spinal muscular atrophy by sodium butyrate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Leukotrienes: lipid bioeffectors of inflammatory reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Primary structure of human PMP69, a putative peroxisomal ABC-transporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Biochemistry of peroxisomes in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Oxidation of very-long-chain fatty acids in rat brain: cerotic acid is beta-oxidized exclusively in rat brain peroxisomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Molecular Species of Phosphatidylcholine Containing Very Long Chain Fatty Acids in Human Brain: Enrichment in X-Linked Adrenoleukodystrophy Brain and Diseases of Peroxisome Biogenesis Brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Nucleotide sequence of the human 70 kDa peroxisomal membrane protein: a member of ATP-binding cassette transporters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

27 July 2018

Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

A novel action of histone deacetylase inhibitors in a protein aggresome disease model

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Fatty acid elongases in mammals: their regulation and roles in metabolism

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Prospects: histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

26 September 2018

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

26 September 2018

Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. Some properties and distribution of the -hydroxylation system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3196237

26 September 2018

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M017491

21 January 2018

Lovastatin for X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-α and X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological significance of fatty acid elongation system in adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21891797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1194/JLR.M017491

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

release_crsgbnhik5ckzmouevljvnfw74

1 reference

https://api.fatcat.wiki/v0/release/crsgbnhik5ckzmouevljvnfw74

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35380239&oldid=1861529635"